196 related articles for article (PubMed ID: 35697198)
1. Bimodal Treatment of Hepatocellular Carcinoma by Targeted Minimally Interventional Photodynamic/Chemotherapy Using Glyco-Covalent-Organic Frameworks-Guided Porphyrin/Sorafenib.
Hu J; Hu J; Wu W; Qin Y; Fu J; Liu C; Seeberger PH; Yin J
Acta Biomater; 2022 Aug; 148():206-217. PubMed ID: 35697198
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy.
Hu J; Hu J; Wu W; Qin Y; Fu J; Zhou J; Liu C; Yin J
Acta Biomater; 2022 Oct; 151():588-599. PubMed ID: 36002126
[TBL] [Abstract][Full Text] [Related]
3. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of concurrent photodynamic therapy with indocyanine green and chemotherapy in hepatocellular carcinoma cell lines and mouse models.
Park JS; Park S; Park SJ; Kim SK
J Photochem Photobiol B; 2023 Feb; 239():112642. PubMed ID: 36623346
[TBL] [Abstract][Full Text] [Related]
5. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib and tetrakis (4-carboxyphenyl) porphyrin assembled nanoparticles for synergistic targeted chemotherapy and sonodynamic therapy of hepatocellular carcinoma.
Chen Y; Tan Q; Tang Y; Pang E; Peng R; Lan M; Bai D
Biomater Sci; 2024 Mar; 12(7):1864-1870. PubMed ID: 38411494
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma.
Chen Y; Liu W; Shang Y; Cao P; Cui J; Li Z; Yin X; Li Y
Int J Nanomedicine; 2019; 14():57-74. PubMed ID: 30587985
[TBL] [Abstract][Full Text] [Related]
8. Porphyrin-based covalent organic frameworks as doxorubicin delivery system for chemo-photodynamic synergistic therapy of tumors.
Chen P; Li Y; Dai Y; Wang Z; Zhou Y; Wang Y; Li G
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104063. PubMed ID: 38527660
[TBL] [Abstract][Full Text] [Related]
9. GSH-Triggered NO releasing nanoplatform based on a covalent organic framework for "1 + 1 > 2" synergistic cancer therapy.
Wan X; Zheng T; Wang D; Pan W; Gao Y; Li N; Tang B
Chem Commun (Camb); 2022 Oct; 58(84):11803-11806. PubMed ID: 36184912
[TBL] [Abstract][Full Text] [Related]
10. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent Imaging-Guided Chemo- and Photodynamic Therapy of Hepatocellular Carcinoma with HCPT@NMOFs-RGD Nanocomposites.
Shang Y; Zhang H; Cheng Y; Cao P; Cui J; Yin X; Fan S; Li Y
Int J Nanomedicine; 2022; 17():1381-1395. PubMed ID: 35369034
[TBL] [Abstract][Full Text] [Related]
12. NIR-Triggered and ROS-Boosted Nanoplatform for Enhanced Chemo/PDT/PTT Synergistic Therapy of Sorafenib in Hepatocellular Carcinoma.
Wang C; Cheng X; Peng H; Zhang Y
Nanoscale Res Lett; 2022 Sep; 17(1):92. PubMed ID: 36125619
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib-Conjugated Zinc Phthalocyanine Based Nanocapsule for Trimodal Therapy in an Orthotopic Hepatocellular Carcinoma Xenograft Mouse Model.
Yu XN; Deng Y; Zhang GC; Liu J; Liu TT; Dong L; Zhu CF; Shen XZ; Li YH; Zhu JM
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17193-17206. PubMed ID: 32207914
[TBL] [Abstract][Full Text] [Related]
14. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
Yurdacan B; Egeli U; Guney Eskiler G; Eryilmaz IE; Cecener G; Tunca B
J Pharm Pharmacol; 2019 Jul; 71(7):1119-1132. PubMed ID: 31025377
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression.
Wu MH; Chiu YF; Wu WJ; Wu PL; Lin CY; Lin CL; Hsieh YH; Liu CJ
Environ Toxicol; 2018 Dec; 33(12):1237-1244. PubMed ID: 30187994
[TBL] [Abstract][Full Text] [Related]
16. MOF@COF Nanocapsules Enhance Soft Tissue Sarcoma Treatment: Synergistic Effects of Photodynamic Therapy and PARP Inhibition on Tumor Growth Suppression and Immune Response Activation.
Tai Y; Chen Z; Luo T; Luo B; Deng C; Lu Z; Wen S; Wang J
Adv Healthc Mater; 2024 Apr; 13(11):e2303911. PubMed ID: 38215731
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable oxygen-producing manganese-chelated metal organic frameworks for tumor-targeted synergistic chemo/photothermal/ photodynamic therapy.
Feng L; Chen M; Li R; Zhou L; Wang C; Ye P; Hu X; Yang J; Sun Y; Zhu Z; Fang K; Chai K; Shi S; Dong C
Acta Biomater; 2022 Jan; 138():463-477. PubMed ID: 34718179
[TBL] [Abstract][Full Text] [Related]
18. A MnO
Zhu D; Wang B; Zhu XH; Zhu HL; Ren SZ
Nanomedicine; 2021 Oct; 37():102440. PubMed ID: 34256062
[TBL] [Abstract][Full Text] [Related]
19. Iridium Complex-Loaded Sorafenib Nanocomposites for Synergistic Chemo-photodynamic Therapy of Hepatocellular Carcinoma.
Abuduwaili W; Wang X; Huang AT; Sun JL; Xu RC; Zhang GC; Liu ZY; Wang F; Zhu CF; Liu TT; Dong L; Zhu JM; Weng SQ; Li Y; Shen XZ
ACS Appl Mater Interfaces; 2022 Aug; 14(33):37356-37368. PubMed ID: 35951459
[TBL] [Abstract][Full Text] [Related]
20. A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy.
Li M; Su Y; Zhang F; Chen K; Xu X; Xu L; Zhou J; Wang W
Acta Biomater; 2018 Jul; 75():413-426. PubMed ID: 29859368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
